Acute hepatitis A: Combination of the relapsing and the cholestatic forms, two rare variants

American Journal of the Medical Sciences

Volumn 319, Issue 6, 2000, Pages 417-419

  Rachima, Carmit Maoz ^a   Cohen, Eytan ^a   Garty, Moshe ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Cholestatic hepatitis; Hepatitis A virus; Relapsing hepatitis; Ursodeoxycholic acid.

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CORTICOSTEROID; PREDNISONE; URSODEOXYCHOLIC ACID;

ACUTE HEPATITIS; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTATIC HEPATITIS; CORTICOSTEROID THERAPY; HEPATITIS A; HUMAN; JAUNDICE; LIVER FUNCTION TEST; MALE; PRURITUS; RECURRENT DISEASE;

EID: 0034131029     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)40785-2     Document Type: Article

References (19)

1. Koff RS. Hepatitis A. Lancet 1998;351:1643-9.
2. Koff RS, Galambos JT. Viral hepatitis. In: Schiff L, Schiff ER, editors. Diseases of the liver. 7th ed. Philadelphia: JB Lippincott; 1992. p. 492-577.
3. Havens WP Jr. Infectious hepatitis in the Middle East: a clinical review of 200 cases in a military hospital. JAMA 1944;126:17-23.
4. Havens WP Jr. Viral hepatitis: clinical patterns and diagnosis. Am J Med 1962;32:665-78.
5. Hoagland CL, Shank RE. Infectious hepatitis. A review of 200 cases. JAMA 1946;130:615-23.
6. Eliakim M, Rachmilewitz M. Cholangiolitic manifestations in virus hepatitis. Gastroenterology 1956;31:369-83.
7. Gordon SC, Reddy RK, Schiff L, et al. Prolonged intrahepatic cholestasis secondary to acute hepatitis. Ann Intern Med 1984;101:635-7.
8. Inman RD, Hodge M, Johnston MEA, et al. Arthritis, vasculitis and cryoglobulinemia associated with relapsing hepatitis A infection. Ann Intern Med 1986;105:700-3.
9. Routenberg JA, Dienstag JL, Harrison WO, et al. Food-borne outbreak of hepatitis A: Clinical and laboratory features of acute and protracted illness. Am J Med Sci 1979;278: 123-31.
10. Tanno H, Fay OH, Rojman JA, et al. Biphasic form of hepatitis A virus infection: A frequent variant in Argentina. Liver 1988;8:53-7.
11. Sjogren MH, Tanno H, Fay O, et al. Hepatitis A virus in stool during clinical relapse. Ann Intern Med 1987;106:221-6.
12. Gruer LD, McKendrick MW, Beeching NJ, et al. Relapsing hepatitis associated with hepatitis A virus [letter]. Lancet 1982;2:163.
13. Glikson M, Galun E, Oren R, et al. Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine (Baltimore) 1992;71:14-23.
14. Kaplan MM. Primary biliary cirrhosis. N Eng J Med 1996; 335:1570-80.
15. Stiehl A, Rudolph G, Raedsch R, et al. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology 1990;12: 492-7.
16. Galle PR, Theilmann L, Raedsch R, et al. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 1990;12:486-91.
17. Hofmann AF. Bile acid hepatotoxicity and the rationale of ursodeoxycholic acid therapy in chronic cholestatic liver disease: some hypotheses. In: Paumgartner G, Steihl A, Barbara L, et al, editors. Strategies for the treatment of hepatobiliary diseases. Boston: Kluwer Academic; 1990. p. 13-34.
18. Schiff L. The use of steroids in liver disease. Medicine 1966;45:565-73.
19. Williams R, Billing BH. Action of steroid therapy in jaundice. Lancet 1961;2:392-6.